(Total Views: 94)
Posted On: 03/16/2022 9:19:26 AM
Post# of 23609
$IPA ImmunoPrecise Antibodies (NASDAQ:IPA) is expected to report quarterly loss at $0.13 per share on revenue of $4.14 million.
https://www.benzinga.com/news/earnings/22/03/...0w.twitter
https://www.benzinga.com/news/earnings/22/03/...0w.twitter
(0)
(0)Scroll down for more posts ▼
